EirGenix Inc. (TPE:6589)
Taiwan · Delayed Price · Currency is TWD 44.90
+0.10 (0.22%)
At close: Jun 4, 2026
EirGenix Market Cap
EirGenix has a market cap or net worth of 13.42 billion as of June 5, 2026. Its market cap has decreased by -29.00% in one year.
Market Cap
13.42B
Enterprise Value
11.68B
Revenue
1.13B
Ranking
n/a
PE Ratio
n/a
Stock Price
44.90
Market Cap Chart
Since November 23, 2016, EirGenix's market cap has increased from 4.56B to 13.42B, an increase of 194.51%. That is a compound annual growth rate of 12.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 4, 2026 | 13.59B | -27.22% |
| Dec 31, 2025 | 18.67B | -15.33% |
| Dec 31, 2024 | 22.05B | -28.29% |
| Dec 29, 2023 | 30.75B | -17.85% |
| Dec 30, 2022 | 37.43B | 11.81% |
| Dec 30, 2021 | 33.48B | 245.12% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Nov 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sunmax Biotechnology | 20.67B |
| Lumosa Therapeutics | 20.35B |
| Medigen Vaccine Biologics | 14.81B |
| CHO Pharma | 14.55B |
| TaiMed Biologics | 14.40B |
| Ever Supreme Bio Technology | 12.69B |
| Polaris Group | 11.44B |
| Tanvex BioPharma | 11.09B |